Application of Instaclop Plus (Clopidogrel+Aspirin) in Treatment and Prevention of Thrombosis

Simple item page
dc.creatorSharipova Elvina Midatovna
dc.date2024-05-21
dc.date.accessioned2024-10-12T12:36:10Z
dc.date.available2024-10-12T12:36:10Z
dc.descriptionThe article describes the effectiveness and safety of use in patients of the main class of modern antiplatelet agents used in the clinical practice of a cardiotherapist, interventional cardiologist, general practitioner in the treatment of coronary heart disease and other pathologies of the cardiovascular system based on data from long-term studies conducted in foreign countries and in Uzbekistan. According to these studies, devoted to studying the effectiveness of the combined drug clopidogrel + aspirin, the main clinical and pharmacological descriptions of the drug Instaclop plus, often used in Uzbekistan, are given.en-US
dc.formatapplication/pdf
dc.identifierhttps://journals.proindex.uz/index.php/JSML/article/view/1006
dc.identifier.urihttps://dspace.umsida.ac.id/handle/123456789/37556
dc.languageeng
dc.publisherPro Indexen-US
dc.relationhttps://journals.proindex.uz/index.php/JSML/article/view/1006/847
dc.sourceJournal of Science in Medicine and Life; Vol. 2 No. 5 (2024): Journal of Science in Medicine and Life; 178-184en-US
dc.source2992-9202
dc.subjectdouble antiplatelet therapy, clopidogrel, aspirin, Instaclop plus, clinical pharmacology, safety, effectivenessen-US
dc.titleApplication of Instaclop Plus (Clopidogrel+Aspirin) in Treatment and Prevention of Thrombosisen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Articleen-US
Files
Collections
Journal of Science in Medicine and Life